DRAP Invitation to Bid: Equipment for National Control Laboratory for Biological (NCLB) FY 2026-27
DRAP Invitation to Bid · Islamabad · The News International,
Tender advertisement published in The News International on Sunday, 13 September 2026, listed under Islamabad. Issued by DRAP Invitation to Bid. The last date printed on the advertisement was Wednesday, 30 September 2026 and has passed.
The original image is temporarily unavailable. Use the source link or the details below. Open the full-size clipping Advertisement details
The Drug Regulatory Authority of Pakistan (DRAP) invites sealed e-bids from EPADS v2.0-registered eligible bidders for the purchase of equipments/instruments for the National Control Laboratory for Biological (NCLB) for FY 2026-27.
| Issuer | Drug Regulatory Authority of Pakistan (Prime Minister's National Health Complex, Park Road, Islamabad) |
|---|---|
| Tender / Reference No. | No. F.28-3/2026-PL (Admn) |
| Purpose | Purchase of equipments / instruments for National Control Laboratory for Biological (NCLB) for FY 2026-27 |
| Eligibility | Only bidders registered on EPADS v2.0 and meeting terms & specifications in the e-bidding documents |
| How to submit | Submit e-bids through EPADS v2.0 only. Manual/physical bids will not be entertained. |
| e-Bidding documents & details | Available at: https://epads.gov.pk/opportunities/federal/procurements/103705 |
| Submission deadline | 2026-09-30 11:00 AM (e-bids must be submitted on or before this time) |
| Bid opening | 2026-09-30 at 11:30 AM (the same day) |
| Contact | Taimur Ali Shah, Assistant Director (Procurement & Logistics), Ph: 051-9255954, Email: [email protected] |
Interested bidders should review the e-bidding documents for full terms, conditions, specifications and submission instructions available on EPADS before applying.
Published in The News International on Sunday, 13 September 2026. DailyAds.pk indexes newspaper advertisements; the original notice and the issuing organisation remain the source for final terms and eligibility.